Plain-English translation of NCT07259174 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying whether a simple ultrasound scan of your diaphragm — the muscle that helps you breathe — can help doctors better understand and predict outcomes when you're admitted to the hospital for a serious flare-up of chronic obstructive pulmonary disease (COPD). Researchers want to see if measuring how much your diaphragm moves during breathing can serve as an important health indicator during these critical periods.
When COPD flares up severely, doctors need better ways to assess how sick patients are and predict who will recover quickly versus who may have complications. This ultrasound measurement could provide a quick, non-invasive way to evaluate your breathing muscle function and help guide your care.
You likely qualify if…
You likely don't qualify if…
When you're admitted to the hospital for your COPD flare-up, you will receive one ultrasound scan of your diaphragm (the muscle below your lungs that controls breathing). This is a painless imaging test similar to the ultrasounds used during pregnancy — the technician will use a small probe on your chest or abdomen while you breathe normally. There are no additional study visits or interventions after this initial scan.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Netherlands